Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026)
Alkermes (ALKS) posted quarterly Long-Term Deferred Tax of $123.0 million for Q2 2026, down 20.89% year-over-year from $155.5 million in Q2 2025, and down 8.73% quarter-over-quarter from $134.8 million in Q1 2026.
Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Long-Term Deferred Tax for 16 consecutive years, with $123.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 20.89% year-over-year to $123.0 million; the TTM figure through Jun 2026 stood at $123.0 million (down 20.89% YoY), while the FY2025 annual figure was $125.8 million, down 18.74% from the prior year.
- Long-Term Deferred Tax retreated to $123.0 million in Q2 2026 per ALKS's latest filing, from $134.8 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $195.9 million in Q4 2023 and bottomed at $112.5 million in Q1 2022.
- Historically, Long-Term Deferred Tax has averaged $146.5 million across 5 years, with a median of $151.7 million in 2023.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax jumped 70.97% — and 2024, when it slipped 20.96%.
- Alkermes' Long-Term Deferred Tax stood at $114.6 million in 2022, then surged by 70.97% to $195.9 million in 2023, then slipped by 20.96% to $154.8 million in 2024, then dropped by 18.74% to $125.8 million in 2025, then dropped by 2.2% to $123.0 million in 2026.
- Business Quant data shows ALKS's Long-Term Deferred Tax at $123.0 million in Q2 2026, $134.8 million in Q1 2026, and $125.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 123.04 Mn |
| Mar 31, 2026 | 134.81 Mn |
| Dec 31, 2025 | 125.82 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Jun 30, 2025 | 155.53 Mn |
| Mar 31, 2025 | 152.14 Mn |
| Dec 31, 2024 | 154.84 Mn |
| Sep 30, 2024 | 159.96 Mn |
| Jun 30, 2024 | 167.38 Mn |
| Mar 31, 2024 | 182.54 Mn |
| Dec 31, 2023 | 195.89 Mn |
| Sep 30, 2023 | 162.18 Mn |
| Jun 30, 2023 | 153.15 Mn |
| Mar 31, 2023 | 151.23 Mn |
| Dec 31, 2022 | 114.57 Mn |
| Sep 30, 2022 | 137.15 Mn |
| Jun 30, 2022 | 123.70 Mn |
| Mar 31, 2022 | 112.52 Mn |
| Dec 31, 2021 | 81.83 Mn |
| Sep 30, 2021 | 84.50 Mn |